Literature DB >> 10905062

Massive pericardial and pleural effusion with anasarca following allogeneic bone marrow transplantation.

T Ueda1, A Manabe, A Kikuchi, H Yoshino, Y Ebihara, T Ishii, H Yagasaki, T Mitsui, H Hisakawa, A Masunaga, K Tsuji, T Nakahata.   

Abstract

A 10-year-old girl presented with massive pericardial/pleural effusion with anasarca 216 days after an allogeneic bone marrow transplantation from her HLA-matched sibling for relapsed acute lymphoblastic leukemia. She did not show any other symptoms of chronic graft-versus-host disease (GVHD). The antinucleolar antibody was elevated in the blood and the pleural fluid. The lymphocytes in the fluid were mostly CD8+/HLA-DR+, and a majority of CD8+ cells in the blood expressed CD57. These data suggested that she had chronic GVHD. Immunosuppressive therapy including prednisolone, cyclosporin A, high-dose methylprednisolone, tacrolimus (FK506), and methotrexate had no effect, and the patient died of Aspergillus pneumonia 183 days after the presentation of the disease. Although it has not been described before, isolated serositis with edema should be recognized as a clinical feature of chronic GVHD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10905062

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  7 in total

Review 1.  Filgrastim treatment of acute myelogenous leukemia (M7) relapse after allogeneic peripheral stem cell transplantation resulting in both graft-versus-leukemia effect with cytogenetic remission and chronic graft-versus-host disease manifesting as polyserositis and subsequent bronchiolitis obliterans with organizing pneumonia.

Authors:  L Law; J Tuscano; T Wun; K Ahlberg; C Richman
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  Efficacy of pleural biopsy for diagnosis of pleural effusion due to chronic GVHD after hematopoietic stem cell transplantation.

Authors:  Masashi Miyauchi; Akihide Yoshimi; Yasuhito Nannya; Yutaka Takazawa; Motoshi Ichikawa; Masashi Fukayama; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2012-06-09       Impact factor: 2.490

3.  Ascites as a Manifestation of GVHD: a Rare Phenomenon.

Authors:  Bhausaheb Bagal; Mukta Ramadwar; Navin Khattry
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-04       Impact factor: 0.900

4.  Incidence, etiology, and outcome of pleural effusions in allogeneic hematopoietic stem cell transplantation.

Authors:  Dipenkumar Modi; Hyejeong Jang; Seongho Kim; Abhinav Deol; Lois Ayash; Divaya Bhutani; Lawrence G Lum; Voravit Ratanatharathorn; Richard Manasa; Kendra Mellert; Joseph P Uberti
Journal:  Am J Hematol       Date:  2016-07-14       Impact factor: 10.047

5.  Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease.

Authors:  Yasunobu Ishikawa; Saori Nishio; Hiroaki Sasaki; Risshi Kudo; Hideki Goto; Masanori Ito; Akira Suzuki; Yuichiro Fukazawa; Toshio Mochizuki; Takao Koike
Journal:  Clin Exp Nephrol       Date:  2010-12-01       Impact factor: 2.801

6.  Large pericardial effusion as a complication in adults undergoing SCT.

Authors:  M Norkin; V Ratanatharathorn; L Ayash; M H Abidi; Z Al-Kadhimi; L G Lum; J P Uberti
Journal:  Bone Marrow Transplant       Date:  2010-11-29       Impact factor: 5.483

7.  The yield and safety of thoracentesis in hematopoietic stem cell transplantation recipients.

Authors:  Abdulgadir K Adam; Mahmud Zamlut; Ayman O Soubani
Journal:  Lung       Date:  2007-08-25       Impact factor: 3.777

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.